KKR Nears Deal to Buy Stake in Cotiviti From Veritas Capital

null By Laura Cooper and Chris CummingUpdated Dec. 11, 2023 4:36 pm ET|WSJ ProKKR has had an active year in deal making. Photo: brendan mcdermid/ReutersPrivate-equity firm Veritas Capital is close to a deal to sell a stake in Cotiviti to alternative-asset manager KKR in a deal that would value the healthcare-technology company at around $11 billion.KKR could finalize an agreement to buy a 50% stake in Cotiviti from Veritas as soon as in the coming weeks, people familiar with the matter said, assuming the talks don’t fall apart.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

A person who loves writing, loves novels, and loves life.Seeking objective truth, hoping for world peace, and wishing for a world without wars.
KKR Nears Deal to Buy Stake in Cotiviti From Veritas Capital
null
KKR has had an active year in deal making. Photo: brendan mcdermid/Reuters

Private-equity firm Veritas Capital is close to a deal to sell a stake in Cotiviti to alternative-asset manager KKR in a deal that would value the healthcare-technology company at around $11 billion.

KKR could finalize an agreement to buy a 50% stake in Cotiviti from Veritas as soon as in the coming weeks, people familiar with the matter said, assuming the talks don’t fall apart.

Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow